Vancomycin prodrug (compound 13c) is a prodrug of Vancomycin. It exhibits antibacterial activity against Staphylococcus aureus (S. aureus) 330041, methicillin-resistant Staphylococcus aureus (MRSA) USA 300, and MRSA 3390, with minimum inhibitory concentrations (MICs) of 0.78 µM, 0.78 µM, and 1.56 µM, respectively. This prodrug can rapidly bind to the Cys-34 residue in plasma. It demonstrates therapeutic efficacy in mice infected with MRSA USA300, comparable to Vancomycin. As an albumin-binding, acid-sensitive prodrug, Vancomycin prodrug maintains Vancomycins effectiveness against gram-positive bacterial infections while significantly reducing nephrotoxicity.
Formula:
C85H95Cl2N11O29
Target:
Autophagy|||Antibiotic|||Antibacterial
* VAT and and shipping costs not included. Errors and price changes excepted
